Publication Name	World Journal of Gastroenterology
Manuscript ID	80117
Country	Serbia

Received	2022-09-17 11:25
Peer-Review Started	2022-09-17 11:27
To Make the First Decision
Return for Revision	2022-11-15 07:50
Revised	2022-12-25 13:33
Second Decision	2023-01-20 03:30
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-01-22 19:01
Articles in Press	2023-01-22 19:01
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-01-27 00:43
Typeset the Manuscript	2023-01-30 05:16
Publish the Manuscript Online	2023-02-06 12:22

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Outcomes of COVID-19 among patients with liver disease
Manuscript Source	Invited Manuscript
All Author List	Isidora Vujčić
ORCID	Author(s) ORCID Number Isidora Vujčić http://orcid.org/0000-0003-3442-7400
Funding Agency and Grant Number
Corresponding Author	Isidora Vujčić, MD, PhD, Associate Professor, Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Visegradska 26a, Belgrade 11000, Belgrade, Serbia. isidora.vujcic@med.bg.ac.rs
Key Words	Liver disease; COVID-19; Mortality; Prognosis
Core Tip	Drastic lifestyle changes during the coronavirus disease 2019 (COVID-19) pandemic have led to an increase in the incidence of liver disease. Liver damage in COVID-19 infection occurs during disease progression in patients with or without previous liver disorders and represents a risk factor for developing severe illness and death. The prognosis of COVID-19 infection depends predominantly on the patients’ characteristics, present comorbidities, severity of clinical symptoms, laboratory parameters, and imaging features. It is important to examine prognostic factors in COVID-19 disease patients with liver disease because it may improve the outcome.
Publish Date	2023-02-06 12:22
Citation	Vujčić I. Outcomes of COVID-19 among liver disease patients. World J Gastroenterol 2023; 29(5): 815-824
URL	https://www.wjgnet.com/1007-9327/full/v29/i5/815.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i5.815

Full Article (PDF)	WJG-29-815.pdf
Full Article (Word)	WJG-29-815.docx
Manuscript File	80117-Review-FilipodiaCL.docx
Answering Reviewers	80117-Answering reviewers.pdf
Audio Core Tip	80117-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	80117-Conflict-of-interest statement.pdf
Copyright License Agreement	80117-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	80117-Language certificate.pdf
Peer-review Report	80117-Peer-review(s).pdf
Scientific Misconduct Check	80117-Bing-Chen YL-2.png
Scientific Editor Work List	80117-Scientific editor work list.pdf
CrossCheck Report	80117-CrossCheck report.pdf